Menu

Making the Rounds

Circular RNA biogenesis occurs when RNA fragments are bent into closed loops of one or more exons and/or introns.

Jul 16, 2017
Catherine Offord

Circular RNAs often form as the pre-mRNA molecule is processed into its final transcript via splicing, in which introns are removed and exons are linked together. Most circular RNAs are thought to be formed by a process called backsplicing, which joins one end of an exon to the other, or to an upstream exon, forming a circle. Researchers have recently published several models—not all of them necessarily mutually exclusive—to explain how different parts of the RNA molecule are brought into close proximity, encouraging backsplicing and turning a linear sequence into circular RNA.

THE SCIENTIST STAFFTHE SCIENTIST STAFFIn a general backsplicing model, proteins assemble to form the spliceosome that processes transcribed RNA. But instead of splicing exons together in a linear sequence, they join the end of one exon to the beginning of the same exon or to an upstream exon. Below are three mechanisms that can drive this backsplicing

INTRON-PAIRING-DRIVEN CIRCULARIZATION

Complementary base pairs formed between long intronic sequences on different parts of the transcript bring together different splice sites on an RNA molecule, promoting backsplicing.

LARIAT-DRIVEN CIRCULARIZATION

Splicing proteins “skip” some exons, creating an exon-containing lariat—a lasso-shaped structure that introns frequently form during standard splicing. This lariat can be excised and formed into a circle while the leftover RNA forms a linear transcript that lacks the skipped exons.

PROTEIN FACTOR–MEDIATED CIRCULARIZATION

RNA-binding proteins (RBPs) such as Quaking bind to sequences on either side of exons and pull these sequences into proximity with each other, forming circles even in transcripts that are normally spliced in a linear fashion.

THE SCIENTIST STAFF

Read the full story.

February 2019

Big Storms Brewing

Can forests weather more major hurricanes?

Marketplace

Sponsored Product Updates

Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that its QXDx AutoDG ddPCR System, which uses Bio-Rad’s Droplet Digital PCR technology, and the QXDx BCR-ABL %IS Kit are the industry’s first digital PCR products to receive U.S. Food and Drug Administration (FDA) clearance. Used together, Bio-Rad’s system and kit can precisely and reproducibly monitor molecular response to treatment in patients with chronic myeloid leukemia (CML).
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) today showcases new automation features of its ZE5 Cell Analyzer during the Society for Laboratory Automation and Screening 2019 International Conference and Exhibition (SLAS) in Washington, D.C., February 2–6. These capabilities enable the ZE5 to be used for high-throughput flow cytometry in biomarker discovery and phenotypic screening.
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Researchers to benefit from an innovative software-connected pipetting system, bringing improved reproducibility and traceability of experiments to life-science laboratories.
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Incorporated (NYSE: GLW) will showcase advanced 3D cell culture technologies and workflow solutions for spheroids, organoids, tissue models, and applications including ADME/toxicology at the Society for Laboratory Automation and Screening (SLAS) conference, Feb. 2-6 in Washington, D.C.